Viral dynamics among HCV infected patients with different genotypes treated with genotypic specific or pan-genotypic direct-acting antiviral agent combinations

BACKGROUND: New hepatitis C virus (HCV) therapies have improved efficacy, allowed pangenotypic applications, increased barriers to drug resistance and shortened therapy duration. METHODS: Patients infected with different HCV genotypes were divided into two groups: group 1 included 169 patients recei...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Infect Drug Resist
Glavni autori: Paolucci, Stefania, Novazzi, Federica, Piralla, Antonio, Maserati, Renato, Gulminetti, Roberto, Novati, Stefano, Barbarini, Giorgio, Sacchi, Paolo, Fratini, Alice, Bellotti, Laura, Baldanti, Fausto
Format: Artigo
Jezik:Inglês
Izdano: Dove 2019
Teme:
Original Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6627173/
https://ncbi.nlm.nih.gov/pubmed/31372005
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IDR.S205282
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items